Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.3275    0.00 (0.00%)
Bid:
0.325
Ask:
0.33
Spread: 0.005 (1.538%)
Market Cap: £25.46m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Director's Dealing

11 Nov 2014 07:00

HAYDALE GRAPHENE INDUSTRIES PLC - Director's Dealing

HAYDALE GRAPHENE INDUSTRIES PLC - Director's Dealing

PR Newswire

London, November 10

Haydale Graphene Industries plc (the "Company") Director's Dealing On 10 November 2014, John Knowles, Chairman of the Company purchased 40,729ordinary shares of 2p each at a price of 61.38p per share and following thistransaction he is now interested in 113,183 ordinary shares of 2p each in theCompany, representing 0.99% of the total voting rights of the Company of11,446,446 shares. For further information please contact: Haydale Graphene Industries plc 01269 842 946John Knowles, ChairmanRay Gibbs, Chief Executive Officer Cairn Financial Advisers LLP (Nomad) 020 7148 7900Tony RawlinsonPaul Trendell Cantor Fitzgerald Europe (Broker)David Foreman 020 7894 7684Paul Jewell 020 7894 7644 Hermes Financial PRTrevor Phillips 07889 153 628Chris Steele 07979 604 687
Date   Source Headline
15th Mar 20197:00 amRNSHolding(s) in Company
14th Mar 20197:00 amRNSDirector/PDMR Shareholding
12th Mar 201911:19 amRNSResult of General Meeting
12th Mar 20197:00 amRNSResult of Open Offer
1st Mar 201912:04 pmRNSHolding(s) in Company
27th Feb 20192:00 pmRNSPrice Monitoring Extension
26th Feb 20191:34 pmRNSHolding(s) in Company
22nd Feb 20194:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20194:35 pmRNSPrice Monitoring Extension
22nd Feb 201912:54 pmRNSResult of Placing and Subscription
22nd Feb 201911:05 amRNSSecond Price Monitoring Extn
22nd Feb 201911:00 amRNSPrice Monitoring Extension
22nd Feb 20197:01 amRNSProposed Placing and Open Offer
22nd Feb 20197:00 amRNSInterim Results
20th Feb 20192:06 pmRNSSecond Price Monitoring Extn
20th Feb 20192:00 pmRNSPrice Monitoring Extension
20th Feb 20199:00 amRNSPrice Monitoring Extension
20th Feb 20197:00 amRNSComment on Speculation
21st Jan 20197:00 amRNSHolding(s) in Company
15th Jan 20197:21 amRNSAgreement for Functionalised Piezoresistive Ink
14th Jan 20197:00 amRNSDirector/PDMR Shareholding
14th Jan 20197:00 amRNSHolding(s) in Company
7th Jan 20194:15 pmRNSFurther re Issue of Equity
4th Jan 201911:51 amRNSDirector/PDMR Shareholding
28th Dec 20187:00 amRNSPDMR Shareholding
21st Dec 201812:22 pmRNSResult of AGM
21st Dec 20187:00 amRNSFinance facility, issue of equity, director change
30th Nov 20184:35 pmRNSPrice Monitoring Extension
29th Nov 20187:00 amRNSUpdate on functionalised graphene ink sales
29th Nov 20187:00 amRNSAnnual Report & Notice of AGM
27th Nov 20189:31 amRNSGEIC to join Haydale and Wheelsure collaboration
27th Nov 20189:05 amRNSSecond Price Monitoring Extn
27th Nov 20189:00 amRNSPrice Monitoring Extension
26th Nov 20184:40 pmRNSSecond Price Monitoring Extn
26th Nov 20184:35 pmRNSPrice Monitoring Extension
19th Nov 20187:00 amRNSLicense agreement for anti-counterfeiting product
13th Nov 20187:00 amRNSJoint Development Agreement with Star RFID
12th Nov 201812:40 pmEQSHardman & Co Research: Haydale (HAYD): Enlightenment delayed
9th Nov 20187:00 amRNSFinancing Update
12th Oct 20187:00 amRNSDevelopment funding from Niche Vehicle Network
28th Sep 20182:54 pmRNSDirector Dealing
27th Sep 20189:29 amRNSNOTIFICATION OF MAJOR HOLDINGS
26th Sep 20185:21 pmEQSHardman & Co Research: Haydale (HAYD): Exuberance, reality; enlightenment now to follow
18th Sep 20187:00 amRNSDevelopment Contract with the EIS
18th Sep 20187:00 amRNSFull Year Results
11th Sep 20187:00 amRNSContract Updates & Notice of Results
5th Sep 20187:00 amRNSBoard Changes
13th Aug 20187:00 amRNSDirector Dealing
8th Aug 20183:01 pmRNSNotification of Major Holdings
8th Aug 201811:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.